Positron Emission Tomography (PET) in Oncology - Test2 - elhamkhani - TriplyDB

Positron Emission Tomography (PET) in Oncology

Positron Emission Tomography (PET) in Oncology

http://www.wikidata.org/entity/Q34774840

about

Molecular basis of ligand recognition and transport by glucose transporters Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012 Imaging-based diagnosis of acute renal allograft rejection.Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Hyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused Organs The role of general nuclear medicine in breast cancer Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis Metabolic pathways promoting cancer cell survival and growth Molecular imaging: from bench to clinic.Proliferation and motility of hepatocellular, pancreatic and gastric cancer cells grown in a medium without glucose and arginine, but with galactose and ornithine [18F]Fludarabine-PET in a murine model of multiple myeloma.SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissue.18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer Cancer stratification by molecular imaging.Metastatic nonpalpable invasive lobular breast carcinoma presenting as rectal stenosis: a case report Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma Functional expression of sodium-glucose transporters in cancer.The benefits of cancer screening in kidney transplant recipients: a single-center experience Polymyositis and dermatomyositis as a risk of developing cancer.Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature Nanosensors for early cancer detection and for therapeutic drug monitoring.GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.History and future technical innovation in positron emission tomography.Mitochondria and Cancer.Nuclear medicine for imaging of epithelial ovarian cancer.Mitochondrial pyruvate carrier function and cancer metabolism.Stage-directed individualized therapy in esophageal cancer.Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.Prognostic value of (18)F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation.Comparison of novel multi-level Otsu (MO-PET) and conventional PET segmentation methods for measuring FDG metabolic tumor volume in patients with soft tissue sarcoma.Poor Uptake of Fluorodeoxyglucose in Positron Emission Tomography-Computed Tomography Scan for Intraocular Choroidal Melanoma in Asian Indian Eyes.Combining 18F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma.Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis.Biophotonic markers of malignancy: Discriminating cancers using wavelength-specific biophotons.ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.Survival Prognostic Value of Morphological and Metabolic variables in Patients with Stage I and II Non-Small Cell Lung Cancer.

P2860

Q24338453-A5C39C06-0778-419D-BB16-9F2BBB1094CD Q26746978-5162574A-480B-4212-A1F5-7853C858E153 Q26751438-8B0EA3FC-7DE7-4387-8840-CA82E8105301 Q26766690-92E8382B-9184-4C2E-8FCC-8A6B69440B9F Q26781659-5598E082-6B6B-46D9-B3C6-C7D91168EFC3 Q26801069-955B0233-B35A-460D-BC55-39EF0FFDDD98 Q26853332-B90D1DCD-8B1C-433D-B72C-AA0EBECA9252 Q27345982-FF35966C-957E-4B75-9018-3FF3D044C806 Q28077401-04B4E8C7-6375-4CCB-85B2-92670992881A Q28086940-F9BD5B81-3504-49BA-85A1-D979781E52A9 Q30420478-F1D708B6-7841-4599-9884-0B7C24AAF08B Q33598120-16D07E9D-8F4C-4CB4-A1E2-04B4D1CB1C09 Q33638151-ADFC142A-2B44-43D3-830E-51F8F9000DE7 Q33745862-87545444-B727-457F-9561-7A84D7F0337C Q33829379-AFC89DE3-CEAA-4FCB-B501-9D97C14B0D47 Q35380664-BFB8AA00-9408-48BD-B75B-2B1E54FBC766 Q35551417-8B3D3A5D-08A6-4C5D-9A31-CF028ACA37D8 Q35785243-EC5CBA2B-6597-4B8A-BD49-EB86811B2822 Q35909986-38801495-8D59-44F7-B8C8-CB808008E27F Q36528417-03783EC1-106B-49C0-BE1B-6B47E11E4985 Q36842357-5A8D878D-B674-4A6E-88D1-EC6C2D9D7C27 Q37205882-21C549D3-5411-47E4-8E2B-779C3979E8ED Q38647614-359EB61F-CFE9-4BB5-86B0-8C14F90F1DCF Q38663958-60098A7B-5B23-4104-829C-4A698A0A5976 Q38731565-F08A7A22-E535-44AC-B146-D0FF777B0FE4 Q38760551-A6FEE221-63BE-455F-88DC-F5EB6B25878B Q38777588-7310C8E0-0A62-46C6-82A4-7F8F0FDB4BE9 Q38857330-99163DF4-D36C-4237-A364-8EC29CDA473E Q38888100-149A191E-1691-48C4-8A96-C72F147B0B03 Q38997952-845FFE38-2D0B-4A73-B938-D33DD3836B23 Q41536916-60BDF7E2-1ECF-4848-9613-F69D8932CEDA Q41683896-1ED97B36-2AB1-4EFB-9C5E-409D7D5913A6 Q42016864-6819821E-C717-44FC-A068-6F2C686330AE Q42620760-B5C9A989-AEC6-43DE-81F8-19E208149452 Q43667576-C61E6091-8DD8-4ADC-AAC5-D7DFE4C2220F Q44877607-B7D54732-264E-4642-AD1A-6E39C440E5CA Q46198687-D4DE7AF9-AD59-499E-B3DB-E0A42084B842 Q47640222-80CB3BD9-98DD-45DE-9D27-3B1927878E5A Q48095788-AC709397-A88C-4DD9-9D17-7D03CDEE9CC1 Q48193212-9D8BBA73-BB33-4DD8-89D0-3198B6AEAE3B

P2860

Positron Emission Tomography (PET) in Oncology

http://www.wikidata.org/entity/Q34774840

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Positron Emission Tomography (PET) in Oncology

@ast

Positron Emission Tomography (PET) in Oncology

@en

type

label

Positron Emission Tomography (PET) in Oncology

@ast

Positron Emission Tomography (PET) in Oncology

@en

prefLabel

Positron Emission Tomography (PET) in Oncology

@ast

Positron Emission Tomography (PET) in Oncology

@en

P1433

Q34774840-C7F7E473-E8D8-4170-B5F3-1CB1260E50AB

P1476

Q34774840-C4FB2FAD-2015-41E5-BEC1-8D78E50065D6

P2093

Q34774840-07B3462B-3676-42E7-BA4C-4EAC13111830

Q34774840-5983A30D-E858-4106-9A40-E82A303045E5

Q34774840-CA961F6F-0EC3-4411-9A95-D0BC0D1B5F7D

P2860

Q34774840-009CB152-13D3-4626-BD24-5693049607E8

Q34774840-01497A5C-C386-4E51-8724-BC6DC13ED44A

Q34774840-023E5DC4-B8C8-4741-BDD1-6BA28CF43439

Q34774840-030C1629-AF75-46E5-B0A8-31158D414439

Q34774840-0333AF9A-28CF-4E04-B4A9-11E4112A813C

Q34774840-05B6B3BB-83E5-46F1-B379-9D9FC0DDDCD0

Q34774840-0634A81F-961B-490E-9F52-C71ECDCB16A6

Q34774840-06A4E999-4C78-44F7-B109-0CC2103960E4

Q34774840-06C4EF13-8AAD-4AE7-880F-269BDACA3CD1

Q34774840-06C7CF32-8DE7-435B-8131-ADB81AEC4264

P304

Q34774840-5503D7D8-5283-441A-BD13-A43BF2FC223A

P31

Q34774840-5f2ad115-39e8-4d51-a088-baff282ae200

Q34774840-64E000DE-7751-473D-B9F0-C45EAF49CE6B

P356

Q34774840-C09F9664-6BCF-48F0-BA03-1DD9B9BAD28C

P433

Q34774840-6978DA4A-4A65-47A3-82B9-982AB1BA98E7

P478

Q34774840-5FAF2CFF-4D01-45F7-94C2-F9E449D92AD4

P577

Q34774840-6344395D-7759-4DBE-AFDB-21486C10756A

P5875

Q34774840-50946FF2-2116-46C3-A3FD-E81DDC5035AA

P698

Q34774840-08C39FBE-790F-4C23-B482-AE4302B4FADA

P932

Q34774840-F18842D2-6DE7-440C-A1A3-E63630692BE8

P356

P1433

P1476

Positron Emission Tomography (PET) in Oncology

@en

P2093

Andrea Gallamini

http://www.w3.org/2001/XMLSchema#string

Anna Borra

http://www.w3.org/2001/XMLSchema#string

Colette Zwarthoed

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?

Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment

Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

PET imaging of proliferation with pyrimidines

The new era of staging as a key for an appropriate treatment for esophageal cancer

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Sorafenib in advanced hepatocellular carcinoma

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Revisions in the International System for Staging Lung Cancer

P304

1821-1889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS6041821

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266380149

http://www.w3.org/2001/XMLSchema#string

P698

25268160

http://www.w3.org/2001/XMLSchema#string

P932

4276948

http://www.w3.org/2001/XMLSchema#string